Pyrrolidine dithiocarbamate down-regulates vascular matrix metalloproteinases and ameliorates vascular dysfunction and remodelling in renovascular hypertension

被引:47
作者
Cau, S. B. A. [1 ]
Guimaraes, D. A. [1 ]
Rizzi, E. [1 ]
Ceron, C. S. [1 ]
Souza, L. L. [2 ]
Tirapelli, C. R. [3 ]
Gerlach, R. F. [4 ]
Tanus-Santos, J. E. [1 ]
机构
[1] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Pharmacol, BR-14049900 Ribeirao Preto, SP, Brazil
[2] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biochem, BR-14049900 Ribeirao Preto, SP, Brazil
[3] Coll Nursing Ribeirao Preto, Dept Psychiat Nursing & Human Sci, Sao Paulo, SP, Brazil
[4] Univ Sao Paulo, Dent Sch Ribeirao Preto, Dept Morphol Estomatol & Physiol, BR-14049900 Ribeirao Preto, SP, Brazil
关键词
pyrrolidine dithiocarbamate; 2K1C hypertension; matrix metalloproteinase; vascular remodelling; NF-kappa B; FACTOR-KAPPA-B; SMOOTH-MUSCLE-CELLS; ANGIOTENSIN-II; OXIDATIVE STRESS; ACTIVATION; RATS; INFLAMMATION; INHIBITION; HEART; PROLIFERATION;
D O I
10.1111/j.1476-5381.2011.01360.x
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
BACKGROUND AND PURPOSE Mounting evidence implicates matrix metalloproteinase (MMP) in the vascular dysfunction and remodelling associated with hypertension. We tested the hypothesis that treatment with pyrrolidine dithiocarbamate (PDTC), which interferes with NF-kappa B-induced MMPs gene transcription, could exert antihypertensive effects, prevent MMP-2 and MMP-9 up-regulation, and protect against the functional alterations and vascular remodelling of two-kidney, one clip (2K1C) hypertension. EXPERIMENTAL APPROACH Sham-operated or hypertensive rats were treated with vehicle or PDTC (100 mg.Kg(-1).day(-1)) by gavage for 8 weeks. Systolic blood pressure (SBP) was monitored weekly. Aortic rings were isolated to assess endothelium-dependent relaxations. Quantitative morphometry of structural alterations of the aortic wall was carried out in haematoxylin/eosin sections. Formation of vascular reactive oxygen species (ROS), and inducible (i) NOS and phosphorylated-p65 NF-kappa B subunit expression were measured in the aortas. MMP-2 and MMP-9 aortic levels and gelatinolytic activity were determined by gelatin and in situ zymography and by immunofluorescence. KEY RESULTS Treatment with PDTC attenuated the increases in SBP and prevented the endothelial dysfunction associated with 2K1C hypertension. Moreover, PDTC reversed the vascular aortic remodelling, the increases in aortic ROS levels and in iNOS and phosphorylated-p65 NF-kappa B expression found in 2K1C rats. These effects were associated with attenuation of 2K1C up-regulation of aortic MMP-2 and MMP-9 levels and gelatinolytic activity. CONCLUSION AND IMPLICATIONS These findings suggest that PDTC down-regulates vascular MMPs and ameliorates vascular dysfunction and remodelling in renovascular hypertension, thus providing evidence supporting the suggestion that PDTC is probably a good candidate to be used to treat hypertension.
引用
收藏
页码:372 / 381
页数:10
相关论文
共 36 条
[1]
Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response [J].
Beswick, RA ;
Zhang, HF ;
Marable, D ;
Catravas, JD ;
Hill, WD ;
Webb, RC .
HYPERTENSION, 2001, 37 (02) :781-786
[2]
Birukov KG, 2009, ANTIOXID REDOX SIGN, V11, P1651, DOI 10.1089/ARS.2008.2390
[3]
Vascular inflammation and the renin-angiotensin system [J].
Brasier, AR ;
Recinos, A ;
Eledrisi, MS .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (08) :1257-1266
[4]
Angiotensin II stimulates matrix metalloproteinase secretion in human vascular smooth muscle cells via nuclear factor-κB and activator protein 1 in a redox-sensitive manner [J].
Browatzki, M ;
Larsen, D ;
Pfeiffer, CAH ;
Gehrke, SG ;
Schmidt, J ;
Kranzhöfer, A ;
Katus, HA ;
Kranzhöfer, R .
JOURNAL OF VASCULAR RESEARCH, 2005, 42 (05) :415-423
[5]
Castier Y, 2009, ANTIOXID REDOX SIGN, V11, P1641, DOI 10.1089/ARS.2008.2393
[6]
Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats [J].
Castro, Michele A. ;
Rizzi, Elen ;
Figueiredo-Lopes, Livia ;
Fernandes, Karla ;
Bendhack, Lusiane A. ;
Pitol, Dimitrius Leonardo ;
Gerlach, Raquel E. ;
Tanus-Santos, Jose E. .
ATHEROSCLEROSIS, 2008, 198 (02) :320-331
[7]
Imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases in hypertensive vascular remodeling [J].
Castro, Michele M. ;
Rizzi, Elen ;
Prado, Cibele M. ;
Rossi, Marcos A. ;
Tanus-Santos, Jose E. ;
Gerlach, Raquel Fernanda .
MATRIX BIOLOGY, 2010, 29 (03) :194-201
[8]
Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension [J].
Castro, Michele M. ;
Rizzi, Elen ;
Rodrigues, Gerson J. ;
Ceron, Carla S. ;
Bendhack, Lusiane M. ;
Gerlach, Raquel F. ;
Tanus-Santos, Jose E. .
FREE RADICAL BIOLOGY AND MEDICINE, 2009, 46 (09) :1298-1307
[9]
The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases [J].
Cauwe, Benedicte ;
Van den Steen, Philippe E. ;
Opdenakker, Ghislain .
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2007, 42 (03) :113-185
[10]
Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension [J].
Ceron, C. S. ;
Castro, M. M. ;
Rizzi, E. ;
Montenegro, M. F. ;
Fontana, V. ;
Salgado, M. C. O. ;
Gerlach, R. F. ;
Tanus-Santos, J. E. .
BRITISH JOURNAL OF PHARMACOLOGY, 2010, 160 (01) :77-87